Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
AstraZeneca - Conducting Major Acquisitions
Seeking Alpha
Tue, 06/11/13 - 03:58 pm
AstraZeneca
M&A
GSK
Novartis
Omthera
Pearl Therapeutics
Pfizer
Questcor Surges After Acquiring Rights to Novartis Drug
Bloomberg
Tue, 06/11/13 - 10:41 am
Questcor
Novartis
Synacthen
autoimmune disease
ulcerative colitis
5 Drugs Stocks On The Rise
TheStreet.com
Mon, 06/10/13 - 08:03 pm
Acadia
Novartis
Teva
JNJ
Merck
Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Motley Fool
Mon, 06/10/13 - 10:56 am
Celgene
Abraxane
pancreatic cancer
Novartis
Pfizer
Alliance Pharmaceuticals acquires rights to Novartis' Syntometrine obstetric drug
Pharmaceutical Business Review
Fri, 06/7/13 - 10:49 am
Alliance Pharma
Novartis
Syntometrine
obstetrics
Another Novartis Manufacturing Facility Gets An FDA Lashing
Pharmalot
Tue, 06/4/13 - 12:47 pm
Novartis
FDA
drug manufacturing
Avanir Pharmaceuticals Builds A Pipeline In A Pill
Seeking Alpha
Tue, 06/4/13 - 10:07 am
Avanir
Novartis
Impax Laboratories
GSK
Actavis
Nuedexta
The Fast Paced World Of Advanced Cell Technology: An Interview With Chairman And CEO Gary Rabin
Seeking Alpha
Mon, 06/3/13 - 11:17 am
Advanced Cell Technology
Gary Rabin
Merck
Novartis
Pfizer
stem cells
adult stem cells
Takeda, Biogen, Article One: Intellectual Property
Bloomberg
Fri, 05/31/13 - 09:07 am
Takeda
Biogen Idec
intellectual property
Novartis
Dexilant
generics
Sandoz
Tecfidera
Impax Laboratories
Novartis AG Stock Buy Recommendation Reiterated (NVS)
The Street
Fri, 05/24/13 - 11:10 am
Novartis
Regeneron Shareholders Watching Optina Trial Closely
Seeking Alpha
Thu, 05/23/13 - 11:32 am
Optina
Regeneron
Novartis
Eylea
Ampio Pharmaceuticals
age-related macular degeneration
Lucentis
Novartis Acknowledges Employees Participated In 'Independent' Trials
Forbes
Thu, 05/23/13 - 11:29 am
Novartis
clinical trials
Diovan
Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
Seeking Alpha
Wed, 05/22/13 - 04:42 pm
Gleevec
Ariad Pharmaceuticals
Iclusig
CML
Novartis
chronic myeloid leukemia
Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail
Bloomberg
Wed, 05/22/13 - 08:12 am
Novartis
Alzheimer's disease
Roche
Merck
Baxter International
Will Influenza A H7N9 Generate Opportunities For Pharma?
Seeking Alpha
Tue, 05/21/13 - 10:58 am
H7N9
Flu
Gilead
GSK
Novavax
Novartis
Roche
Sanofi
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/20/13 - 11:40 am
leukemia
Sprycel
Bristol-Myers Squibb
Gleevec
Novartis
Iclusig
Ariad Pharmaceuticals
Bosulif
Pfizer
Erwinaze
Jazz Pharmaceuticals
Idelalisib
Gilead
ibrutinib
Pharmacyclics
Novartis AG (NVS): Today's Featured Drugs Laggard
The Street
Sat, 05/18/13 - 12:10 pm
Novartis
Amgen and Novartis partner with biotech venture capital firm
PM Live
Fri, 05/17/13 - 11:34 am
venture capital
Amgen
Novartis
Atlas Venture
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters
Thu, 05/16/13 - 05:28 pm
Roche
M&A
Novartis
Daniel Vasella
Jury is out in another case linking Novartis' Zometa to jawbone death
Fierce Pharma
Thu, 05/16/13 - 10:23 am
Zometa
Novartis
Pages
« first
‹ previous
…
109
110
111
112
113
114
115
116
117
…
next ›
last »